10,000 cancer patients join ontario Gene-Mapping effort to personalize care

NCT ID NCT02906943

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to collect and analyze tumor samples from 10,000 adults with advanced solid cancers (like breast, lung, or colon cancer) to create a province-wide gene database. The goal is to help doctors identify which targeted drugs or clinical trials might work best for each patient based on their cancer's unique genetic markers. Participants provide previously collected tumor tissue and blood samples, and their health data is linked to other records for future research. No new treatments are tested here, but the information gathered may guide more personalized cancer care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Juravinski Cancer Centre

    ACTIVE_NOT_RECRUITING

    Hamilton, Ontario, Canada

  • Kingston General Hospital

    ACTIVE_NOT_RECRUITING

    Kingston, Ontario, Canada

  • London Health Sciences Centre

    ACTIVE_NOT_RECRUITING

    London, Ontario, Canada

  • Mount Sinai Hospital

    ACTIVE_NOT_RECRUITING

    Toronto, Ontario, Canada

  • Princess Margaret Hospital

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Sunnybrook Health Sciences Centre

    ACTIVE_NOT_RECRUITING

    Toronto, Ontario, Canada

  • The Ottawa Hospital Cancer Centre

    RECRUITING

    Ottawa, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.